Corvus Pharmaceuticals, Inc.
Clinical trials sponsored by Corvus Pharmaceuticals, Inc., explained in plain language.
-
New pill tested to tame severe eczema itch and rash
Disease control Recruiting nowThis study is testing a new oral medication called soquelitinib for adults with moderate to severe eczema (atopic dermatitis). About 200 participants will take either the drug or a placebo pill daily for 12 weeks to see if it safely reduces skin inflammation and itching. Doctors …
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New pill challenges standard care for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing an experimental oral drug called soquelitinib against standard chemotherapy options for adults with specific aggressive T-cell lymphomas that have returned or not responded to prior treatment. About 150 participants will be randomly assigned to receive eithe…
Phase: PHASE3 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC